Puijk Robbert S, Ruarus Alette H, Scheffer Hester J, Vroomen Laurien G P H, van Tilborg Aukje A J M, de Vries Jan J J, Berger Ferco H, van den Tol Petrousjka M P, Meijerink Martijn R
Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands.
Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands.
Can Assoc Radiol J. 2018 Feb;69(1):51-62. doi: 10.1016/j.carj.2017.11.001.
Liver tumour ablation nowadays represents a routine treatment option for patients with primary and secondary liver tumours. Radiofrequency ablation and microwave ablation are the most widely adopted methods, although novel techniques, such as irreversible electroporation, are quickly working their way up. The percutaneous approach is rapidly gaining popularity because of its minimally invasive character, low complication rate, good efficacy rate, and repeatability. However, matched to partial hepatectomy and open ablations, the issue of ablation site recurrences remains unresolved and necessitates further improvement. For percutaneous liver tumour ablation, several real-time imaging modalities are available to improve tumour visibility, detect surrounding critical structures, guide applicators, monitor treatment effect, and, if necessary, adapt or repeat energy delivery. Known predictors for success are tumour size, location, lesion conspicuity, tumour-free margin, and operator experience. The implementation of reliable endpoints to assess treatment efficacy allows for completion-procedures, either within the same session or within a couple of weeks after the procedure. Although the effect on overall survival may be trivial, (local) progression-free survival will indisputably improve with the implementation of reliable endpoints. This article reviews the available needle navigation techniques, evaluates potential treatment endpoints, and proposes an algorithm for quality control after the procedure.
如今,肝肿瘤消融是原发性和继发性肝肿瘤患者的一种常规治疗选择。射频消融和微波消融是应用最广泛的方法,尽管诸如不可逆电穿孔等新技术也在迅速崛起。经皮途径因其微创性、低并发症发生率、良好的有效率和可重复性而迅速受到欢迎。然而,与部分肝切除术和开放性消融相比,消融部位复发的问题仍未得到解决,需要进一步改进。对于经皮肝肿瘤消融,有几种实时成像方式可用于提高肿瘤可视性、检测周围关键结构、引导消融器、监测治疗效果,并在必要时调整或重复能量传递。成功的已知预测因素包括肿瘤大小、位置、病变清晰度(显影程度)、无瘤切缘和操作者经验。实施可靠的终点指标来评估治疗效果,可在同一次治疗过程中或治疗后几周内完成整个治疗流程。尽管对总生存期的影响可能微不足道,但随着可靠终点指标的实施,(局部)无进展生存期无疑会得到改善。本文回顾了现有的针引导技术,评估了潜在的治疗终点指标,并提出了术后质量控制算法。